Home > Advocacy & Initiatives

Advocacy & Initiatives

Access to abortion care has been decimated since the US Supreme Court overturned Roe v. Wade in its 2022 decision in Dobbs v. Jackson Women’s Health Organization. Pharmacists are in a unique position to increase access to medication abortion.

As of January 2023, the FDA Mifepristone REMS Program has removed the in-person dispensing requirement and allows certified pharmacies to dispense mifepristone to patients. To help you deliver medication abortion care, we have created and curated regulatory guidance, training materials, and clinical resources.

Birth Control Pharmacist in partnership with the California Pharmacists Association (CPhA) and the CPhA Foundation are proud to announce the Pharmacists Comprehensive Abortion and Reproductive Health Empowerment (Pharmacists CARE) Initiative to expand medication abortion and comprehensive reproductive health services in California and beyond. This includes the development of a training program and implementation package for pharmacies to become certified to dispense abortion medications and provide the full range of reproductive health services.